PVI ablation significantly reduces #AF burden, and results in clinically important improvements in symptoms and quality of life versus a sham procedure—as per late-breaking research presented at #ESCCongress2024 #ESCCongress European Society of Cardiology Rajdip Dulai cardiacrhythmnews.com/sham-pvi-mains…

As per late-breaking research presented at #ESCcongress2024, cryoballoon ablation is as effective at reducing #AF recurrences and atrial tachycardia at one year, when compared to RF ablation, in HFrEF patients #ESCCongress European Society of Cardiology Koji Miyamoto cardiacrhythmnews.com/crabl-hf-simpl…

.B-Secur has announced the U.S. FDA clearance and launch of HeartKey Rhythm—a suite of #ECG algorithms and analytics designed to enhance clinical confidence, streamline industry efficiency, and improve outcomes for #Cardiac patients cardiacrhythmnews.com/heartkey-rhyth…

Screening for #AF using a wearable heart monitor for two weeks can identify older adults with this abnormal heart rhythm, but does not prevent subsequent strokes, according to late-breaking research presented at #ESCcongress2024 European Society of Cardiology iRhythm Technologies cardiacrhythmnews.com/guard-af-weara…

.Abbott Cardiovascular has announced that it will be rolling out its Aveir dual-chamber (DR) leadless #Pacemaker system for the treatment of abnormal or slow heart rhythms across the UK Abbott cardiacrhythmnews.com/abbott-world-f…

In patients with persistent AF, standard treatment with PVI ablation resulted in similar outcomes to more extensive ablation in other areas of the heart—as per results from the SUPPRESS-AF trial, which were presented at #ESCcongress2024 European Society of Cardiology cardiacrhythmnews.com/suppress-af-ad…

.Boston Scientific has announced the appointment of Angelo Auricchio as chief medical officer of the company’s Rhythm Management business in Europe, the Middle East and Africa (EMEA) BostonSci Cardiology Boston Scientific EMEA - Cardiology cardiacrhythmnews.com/boston-scienti…

Quitting cigarettes can significantly lower a person’s risk of #AFib compared to those who continue to smoke, and the benefits of quitting start right away, as per a recent JACC Journals: Clinical #Electrophysiology study Greg Marcus American College of Cardiology cardiacrhythmnews.com/quitting-smoki…

.Medtronic recently shared long-term results from the global EV ICD trial, reinforcing the performance/safety of its extravascular implantable cardioverter defibrillator system, at the 2024 European Society of Cardiology congress Medtronic Cardiac Medtronic Cardiac Ablation Francis Murgatroyd🇪🇺🇬🇧🇪🇺🇬🇧 cardiacrhythmnews.com/final-results-…

The treatment of #AFib via a novel, ‘single-shot’ spherical array approach to PFA has achieved durable and safe creation of #Cardiac tissue lesions, translating into “good clinical efficacy”, at one-year follow-up Vivek Y. Reddy HeartRhythm Kardium cardiacrhythmnews.com/pulse-eu-singl…

.Merit Medical has announced that it recently signed a definitive asset purchase agreement to purchase Cook Medical's lead management portfolio for a total cash consideration of approximately US$210 million cardiacrhythmnews.com/merit-medical-…

Biosense Webster is one of several companies to have been further incorporated under the Johnson & Johnson MedTech umbrella as part of a recent brand update, and will now go by 'Johnson & Johnson MedTech Electrophysiology' Johnson & Johnson MedTech | Electrophysiology Johnson & Johnson cardiacrhythmnews.com/cerenovus-and-…

.Boston Scientific recently announced late-breaking data from the MODULAR ATP clinical trial investigating the pacing performance of the company’s Empower leadless pacemaker, with findings being delivered by Lluís Mont at the 2024 European Society of Cardiology congress cardiacrhythmnews.com/bostons-empowe…

.Medtronic has announced the presentation of study results demonstrating a high rate of durable lesion formation with the PulseSelect PFA system in treating AF at #APHRS2024 APHRS Official APHRS2024 Medtronic Cardiac Medtronic Cardiac Ablation Dr. Devi G Nair cardiacrhythmnews.com/new-clinical-d…

.Boston Scientific has announced receipt of 独立行政法人 医薬品医療機器総合機構(PMDA) approval in Japan for the Farapulse PFA system, which is indicated for the isolation of pulmonary veins in the treatment of paroxysmal #AFib Boston Scientific CRM/EP UK & IRE BostonSci Cardiology Boston Scientific EMEA - Cardiology Kazuhiro Satomi cardiacrhythmnews.com/boston-scienti…

The Health Policy and Regulatory Affairs Committee of Heart Rhythm Society has published a statement online in the HeartRhythm reaffirming the important role of electrophysiologists in cardiac ablation treatments for atrial fibrillation #EP #AFib Kenneth Ellenbogen cardiacrhythmnews.com/hrs-releases-n…

A patient’s pattern of #AF at initial diagnosis does not influence their rate of AF recurrence, nor their AF burden, following catheter ablation—as per a study presented at APHRS2024 and now published in JACC Journals #APHRS2024 APHRS Official American College of Cardiology cardiacrhythmnews.com/af-pattern-at-…

Adjunctive CSI as part of a de-novo ablation strategy does not confer additional benefit versus PVI plus roofline ablation in the treatment of high-burden #AF, according to a study presented at #APHRS2024 APHRS2024 APHRS Official American College of Cardiology Prash Sanders cardiacrhythmnews.com/adjunctive-cor…